Obesity and its Implications for COVID‐19 Mortality

By W. Dietz, C. Santos‐Burgoa. Obesity, 2020

600 citations recorded by the source corpus.

A recent JAMA viewpoint regarding fatalities In Italy associated with the COVID-19 pandemic failed to mention obesity as one of the pre-existing diseases associated with death.1 It seems likely that the increased prevalence of obesity in Italy older adults compared to China may account for the differences in mortality between the two countries. Furthermore, the rising prevalence of obesity in the US and prior experience of the impact of obesity on mortality from H1 N1 Influenza should increase the sensitivity of clinicians caring for patients with obesity and COVID-19 to the need for aggressive treatment of such patients.

Subfields: Clinical Psychology, Health, Toxicology and Mutagenesis, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/130284969b1e805753b91e3e6f382babc46fe219

Citations in the corpus

• Severe obesity is associated with higher in-hospital mortality in a cohort of patientswith COVID-19 in the Bronx, New York (2020, unknown): “decreased diaphragmatic excursion in supine patients compromising ventilation [23].”